News

WHO covid-19 IP pool launches this week without strong pharma support

Open and global sharing of patents, data and know-how is seen as a step too far by many life sciences innovators

WHO covid-19 IP pool launches this week without strong pharma support
Japanese covid-19 patent pledge triples membership, but users must read fine print
25 May 2020

Japanese covid-19 patent pledge triples membership, but users must read fine print

Big-name electronics and chemical companies have continued to sign on, but several have taken the opportunity to narrow the terms of the pledge and remind potential infringers that they won’t tolerate abuse

Aon’s big IP insurance move; Huawei, Qualcomm, Samsung back new pool; US patent sales soar; Iancu covid-19 licensing exclusive; Uber patenting secrets; plus much more
24 May 2020

Aon’s big IP insurance move; Huawei, Qualcomm, Samsung back new pool; US patent sales soar; Iancu covid-19 licensing exclusive; Uber patenting secrets; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

Latest

View all news
23 May 2020

The coronavirus has ended all hope of US patent eligibility reform

Opponents of stronger laws have seized the opportunity created by the pandemic to build a narrative that will make legislative changes to the 101 regime almost impossible to secure Read more

22 May 2020

Iancu on new USPTO licensing platform – “IP will play critically important role in fighting pandemic”

The agency's Patents 4 Partnerships initiative is designed to help rights owners make relevant assets available in fight against covid-19 Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

20 May 2020

From the archive – Japan’s patent story

A look into the IAM back catalogue to see how we have covered the developing face of IP strategy in one of the world's great innovation powers Read more

20 May 2020

IP Hall of Fame 2020 inductees announced

A UK Supreme Court justice, a former USPTO acting director, a globally-renowned IP scholar, a trailblazing trademark lawyer and a one-time presidential candidate form the class of 2020 Read more

18 May 2020

PGR decision provides much-needed clarity in fast-growing microbiome space

First post-grant decision in the technology sector nevertheless gives some hope to gut bacteria innovators, despite invalidating a key cancer treatment patent Read more

17 May 2020

Ominous covid-19 signs for IP; Acacia lands Yahoo! patents; Gamechanging German FRAND ruling; Top EPO filing firms; WiLAN’s huge IBM chip patent deal; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

16 May 2020

IP is here to stay, but everything is going to change

As IAM celebrates its 100th issue, a look back at how it all began, a fast forward to the future and a massive thank-you Read more

15 May 2020

Patent owners should prepare for further PTAB changes

From key case law to radical new ways of working, four leading experts share their predictions about what might happen next at the board Read more

15 May 2020

Five key takeaways from Akebia v Fibrogen

UK High Court judgment highlights vulnerability of broad Markush claims Read more

14 May 2020

From the archive – IV through the years

A look in to the IAM back catalogue to see how we have covered the evolution of the pioneering patent market player Read more

14 May 2020

Why patent practitioners are warming to Iancu’s PTAB reforms

Leading experts put recent changes to post-issuance reviews under the microscope and like what they see Read more

13 May 2020

Ominous signs for the global IP market in a covid-19 world

Leading in-house and private practice lawyers share their experiences of working in the shadow of a pandemic and explain what they believe might happen next Read more

12 May 2020

How to win post-issuance reviews at the PTAB

Thought leaders from key US law firms debate how to maximise the chances of success in an inter partes review Read more

10 May 2020

USPTO backlog warning; Todd Dickinson RIP; Japanese giants make covid-19 patent pledge; Strong quarters for licensing leaders; NPE targets eight with former Blackberry IP; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

9 May 2020

Patent dealmaking cannot escape the effects of worsening Sino-US relations

Despite the improving Chinese IP environment and trade deal commitments, long-term personal relationships are likely to be increasingly important in getting transactions over the line Read more

7 May 2020

"The entire environment has put a really big spotlight on tech transfer," says University of Kentucky licensing head

Ian McClure explains why the current covid-19 crisis could herald a revolution in the academic institutions’ licensing efforts, but also warns of potential dangers ahead Read more

7 May 2020

Top Japanese corporates pledge patent non-assertion to speed virus fight

Canon and 15 other companies in tech, auto and healthcare make Open Covid-19 Declaration Read more

6 May 2020

From the archive – behind the numbers

A look into our back catalogue to see how IAM has covered the rapidly changing world of patent analytics Read more

6 May 2020

How the USPTO has responded to the covid-19 pandemic

The agency's former Commissioner of Patents says it’s so far so good at the office - but explains why a backlog may build at the end of the year Read more

5 May 2020

Todd Dickinson - a tribute

A champion of US innovation and IP departs way too early but leaves a legacy of achievement that very few will ever match Read more

3 May 2020

Patent filings set to rise; Spangenberg makes AI acquisition; Merck and Konica Minolta seal huge patent deal; IBM sells more IP; NPE targets Tesla; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

2 May 2020

It’s a downturn Jim, but not as IP owners know it

Patent rights may fare well in a recession but this is a global market unlike any other we have seen before Read more

30 Apr 2020

IP is crucial to finding breakthrough covid-19 medicines, Novartis policy head states

“We are only in the position to tackle the pandemic, because of where the system has brought us so far,” says Corey Salsberg in an exclusive interview with IAM Read more

29 Apr 2020

From the archive – The rise of China IP Inc

A look into the IAM back catalogue to see how we have charted the rise of an IP superpower Read more

28 Apr 2020

How IP owners have responded to the covid-19 challenge so far

Several innovators have already waived exclusivities, but big decisions for right holders lie ahead Read more

26 Apr 2020

SEP covid-19 dangers; Japan IoT injunction threat; Patent filings bounce back in China; PE firm buys majority Ocean Tomo stake; Comcast spends big to beat TiVo; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

25 Apr 2020

SEP owners face a moment of maximum danger

Mobile devices will play a major role in the recovery from the covid-19 crisis - and that means how much they cost is going to come firmly under the microscope Read more

24 Apr 2020

Now, more than ever, companies must optimise the value of their patent portfolios

Free webinar next Tuesday will focus on findings of exclusive survey of corporate IP leaders and strategies to maximise the reach and value of holdings as cost-effectively as possible Read more

22 Apr 2020

Let’s be thankful for a billion miles of IP

The amazing technologies that power the internet have kept us connected as the covid-19 pandemic has raged. This connectivity is down to the investments and contributions made by patent owners Read more

22 Apr 2020

Chinese patent filings fell in first quarter, but real virus impact could be ahead

February lockdown cratered CNIPA applications, but March brought a significant rebound as Beijing-based patent agencies and law firms began to approach normal capacity Read more

20 Apr 2020

How UK Crown Use provisions apply to suppliers of emergency Covid-19 treatments

Altruistic rights holders may also provide access to their IP without permitting post-pandemic use Read more

19 Apr 2020

Covid-19 vaccine exclusive; Huawei’s big NPE deal; Top antiviral patent owners named; No US litigation drop – yet; Major IP investment opportunities revealed; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

18 Apr 2020

Intellectual Discovery and IP Bridge sales mark the end of an era

The state-backed patent funds helped change the culture around patents in the South Korea and Japan, and now both face the task of surviving the private sector Read more

17 Apr 2020

Johnson & Johnson, Gilead and Roche are the world’s antiviral patent leaders

A covid-19 vaccine could be produced by anyone, but only a few major players had been actively strengthening and building their portfolios before the pandemic struck Read more

View all news